Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | PAN domain-containing protein | 0.0998 | 1 | 1 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Entamoeba histolytica | hypothetical protein, conserved | 0.094 | 0.937 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.094 | 0.937 | 0.5 |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.094 | 0.937 | 0.5 |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.094 | 0.937 | 1 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Echinococcus granulosus | sphingosine kinase 1 | 0.094 | 0.937 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.094 | 0.937 | 0.5 |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Brugia malayi | PAN domain containing protein | 0.0064 | 0 | 0.5 |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Onchocerca volvulus | 0.0064 | 0 | 0.5 | |
Echinococcus multilocularis | sphingosine kinase 1 | 0.094 | 0.937 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 0.094 | 0.937 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.